Barbara Ryan
Insider
First SEC filing: Jan. 7, 2026 · Latest: June 5, 2026
Insider at
Insider transactions
3 buys (P)
8 sells (S)
Net: $-17,935
Avg return of open purchases vs now: 8.5%
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 1, 2026 | INKT | A | 1,622 | $10.95 | $17,761 | 23,591 Direct | +7.38% | Acquired | 13.6% (price as of 2026-10-02) |
| June 4, 2026 | INKT | S | 1,000 | $12.80 | $12,800 | 21,969 Direct | -4.35% | Disposed | -2.8% (price as of 2026-10-02) |
| June 4, 2026 | INKT | S | 500 | $12.68 | $6,340 | 22,969 Direct | -2.13% | Disposed | -1.9% (price as of 2026-10-02) |
| June 1, 2026 | INKT | A | 1,434 | $12.38 | $17,753 | 23,469 Direct | +6.51% | Acquired | 0.5% (price as of 2026-10-02) |
| May 13, 2026 | INDV | A | 6,518 | · | · | 12,242 Direct | +113.87% | Acquired | (price as of 2026-10-02) |
| March 13, 2026 | INDV | P | 8 | $31.08 | $249 | 5,724 Direct | +0.14% | Acquired | 14.9% (price as of 2026-10-02) |
| March 10, 2026 | INKT | S | 500 | $15.30 | $7,650 | 20,406 Direct | -2.39% | Disposed | -18.7% (price as of 2026-10-02) |
| March 10, 2026 | INKT | S | 500 | $15.57 | $7,785 | 20,906 Direct | -2.34% | Disposed | -20.1% (price as of 2026-10-02) |
| March 10, 2026 | INKT | S | 300 | $15.28 | $4,584 | 21,406 Direct | -1.38% | Disposed | -18.6% (price as of 2026-10-02) |
| March 9, 2026 | INDV | P | 31 | $32.56 | $1,009 | 5,716 Direct | +0.55% | Acquired | 9.7% (price as of 2026-10-02) |
| March 9, 2026 | INKT | S | 200 | $10.17 | $2,034 | 21,706 Direct | -0.91% | Disposed | 22.3% (price as of 2026-10-02) |
| March 2, 2026 | INKT | A | 1,629 | $10.90 | $17,756 | 22,035 Direct | +7.98% | Acquired | 14.1% (price as of 2026-10-02) |
| March 2, 2026 | INKT | S | 100 | $10.83 | $1,083 | 21,906 Direct | -0.45% | Disposed | 14.9% (price as of 2026-10-02) |
| Feb. 27, 2026 | INKT | S | 400 | $10.86 | $4,344 | 22,006 Direct | -1.79% | Disposed | 14.5% (price as of 2026-10-02) |
| Jan. 26, 2026 | INDV | A | 3,722 | · | · | 5,685 Direct | +189.61% | Acquired | (price as of 2026-10-02) |
| Jan. 5, 2026 | INDV | P | 775 | $35.39 | $27,427 | 1,963 Direct | +65.24% | Acquired | 0.9% (price as of 2026-10-02) |
| Jan. 2, 2026 | INKT | A | 5,395 | · | · | 5,395 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 1, 2025 | INKT | A | 1,601 | $11.09 | $17,755 | 22,406 Direct | +7.70% | Acquired | 12.2% (price as of 2026-10-02) |
| Sept. 9, 2025 | INKT | A | 3,225 | · | · | 3,225 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2025 | INKT | A | 1,281 | $13.86 | $17,755 | 20,805 Direct | +6.56% | Acquired | -10.2% (price as of 2026-10-02) |
| Aug. 26, 2025 | IVF | A | 45,000 | · | · | 45,157 Direct | +28662.42% | Acquired | (price as of 2026-10-02) |
| June 2, 2025 | INKT | A | 2,476 | $7.17 | $17,753 | 19,524 Direct | +14.52% | Acquired | 73.5% (price as of 2026-10-02) |
| March 3, 2025 | INKT | A | 2,019 | $8.79 | $17,747 | 17,048 Direct | +13.43% | Acquired | 41.5% (price as of 2026-10-02) |
| Dec. 1, 2024 | INKT | A | 24,229 | $0.73 | $17,687 | 150,336 Direct | +19.21% | Acquired | 70.4% (price as of 2026-10-02) |
| Sept. 3, 2024 | INKT | A | 21,649 | $0.82 | $17,752 | 126,107 Direct | +20.73% | Acquired | 51.7% (price as of 2026-10-02) |
| June 3, 2024 | INKT | A | 17,841 | $0.99 | $17,663 | 104,458 Direct | +20.60% | Acquired | 25.7% (price as of 2026-10-02) |
| March 1, 2024 | INKT | A | 18,685 | $0.95 | $17,751 | 86,617 Direct | +27.51% | Acquired | 30.9% (price as of 2026-10-02) |
| Dec. 1, 2023 | INKT | A | 17,068 | $1.04 | $17,751 | 67,932 Direct | +33.56% | Acquired | 19.6% (price as of 2026-10-02) |
| Sept. 1, 2023 | INKT | A | 12,158 | $1.46 | $17,751 | 50,864 Direct | +31.41% | Acquired | -14.8% (price as of 2026-10-02) |
| June 14, 2023 | INKT | A | 37,500 | · | · | 37,500 Direct | · | Acquired | (price as of 2026-10-02) |
| June 1, 2023 | INKT | A | 10,086 | $1.76 | $17,751 | 38,930 Direct | +34.97% | Acquired | -29.3% (price as of 2026-10-02) |
| May 18, 2023 | IVF | A | 85,000 | · | · | 85,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 1, 2023 | INKT | A | 8,493 | $2.09 | $17,750 | 28,844 Direct | +41.73% | Acquired | -40.5% (price as of 2026-10-02) |
| Dec. 1, 2022 | INKT | A | 6,801 | $2.61 | $17,751 | 20,351 Direct | +50.19% | Acquired | -52.3% (price as of 2026-10-02) |
| Sept. 15, 2022 | INKT | A | 13,550 | $2.62 | $35,501 | 13,550 Direct | · | Acquired | -52.5% (price as of 2026-10-02) |
| June 1, 2022 | IVF | P | 10,526 | $0.95 | $10,000 | 22,991 Direct | +84.44% | Acquired | -100.0% (price as of 2026-10-02) |
| March 9, 2022 | INKT | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 15, 2022 | IVF | A | 8,588 | · | · | 21,053 Direct | +68.90% | Acquired | (price as of 2026-10-02) |
| Jan. 15, 2022 | IVF | A | 10,435 | · | · | 10,435 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2020 | IVF | A | 13,574 | · | · | 13,574 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2020 | IVF | A | 10,148 | · | · | 12,465 Direct | +437.98% | Acquired | (price as of 2026-10-02) |
| Nov. 27, 2020 | IVF | A | 2,317 | · | · | 2,317 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 27, 2020 | IVF | A | 2,317 | · | · | 2,317 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | INKT | Stock Option (Right to Buy) | Common Stock | $11.12 | Jan. 2, 2036 | 5,395 | Acquired |
| Sept. 9, 2025 | INKT | Stock Option (Right to Buy) | Common Stock | $15.36 | Sept. 9, 2035 | 3,225 | Acquired |
| Aug. 26, 2025 | IVF | Stock Option (right to buy) | Common Stock | $1.01 | Aug. 26, 2035 | 45,000 | Acquired |
| June 14, 2023 | INKT | Stock Option (Right to Buy) | Common Stock | $2.27 | June 14, 2033 | 37,500 | Acquired |
| May 18, 2023 | IVF | Stock Option (right to buy) | Common Stock | $0.37 | May 17, 2033 | 85,000 | Acquired |
| March 9, 2022 | INKT | Stock Option (Right to Buy) | Common Stock | $2.89 | March 9, 2032 | 25,000 | Acquired |
| Jan. 15, 2022 | IVF | Stock Option | Common Stock | $3.61 | Jan. 14, 2032 | 10,435 | Acquired |
| Dec. 31, 2020 | IVF | Stock Option | Common Stock | $3.06 | Dec. 31, 2030 | 13,574 | Acquired |
| Nov. 27, 2020 | IVF | Stock Option | Common Stock | $3.19 | Nov. 27, 2025 | 2,317 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.